Lantheus Holdings, Inc. (LNTH) stock
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$101.80+0.08 (+0.08%)
Close on Nov 17, 2026Market cap $6.64BP/E 24.6Yield –
Lantheus revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Lantheus's revenue for the twelve months ending Jun 30, 2026 was $1.56B, up 2.3% year over year. For fiscal 2025 it was $1.54B, up 0.5% from the year before. Over ten years it grew 18.0% a year on average. The highest annual figure on record is $1.54B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.54B | +0.5% |
| FY2024 | Dec 31, 2024 | $1.53B | +18.3% |
| FY2023 | Dec 31, 2023 | $1.30B | +38.6% |
| FY2022 | Dec 31, 2022 | $935.06M | +119.9% |
| FY2021 | Dec 31, 2021 | $425.21M | +25.3% |
| FY2020 | Dec 31, 2020 | $339.41M | -2.3% |
| FY2019 | Dec 31, 2019 | $347.34M | +1.2% |
| FY2018 | Dec 31, 2018 | $343.37M | +3.6% |
| FY2017 | Dec 31, 2017 | $331.38M | +9.8% |
| FY2016 | Dec 31, 2016 | $301.85M | +2.9% |
| FY2015 | Dec 31, 2015 | $293.46M | -2.7% |
| FY2014 | Dec 31, 2014 | $301.60M | +6.3% |
| FY2013 | Dec 31, 2013 | $283.67M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $388.18M | +2.7% |
| Q1 FY2026 | Mar 31, 2026 | $377.33M | +1.2% |
| Q4 FY2025 | Dec 31, 2025 | $406.79M | +4.0% |
| Q3 FY2025 | Sep 30, 2025 | $384.01M | +1.4% |
| Q2 FY2025 | Jun 30, 2025 | $378.05M | -4.1% |
| Q1 FY2025 | Mar 31, 2025 | $372.76M | +0.8% |
| Q4 FY2024 | Dec 31, 2024 | $391.11M | +10.5% |
| Q3 FY2024 | Sep 30, 2024 | $378.73M | +18.4% |
| Q2 FY2024 | Jun 30, 2024 | $394.09M | +22.5% |
| Q1 FY2024 | Mar 31, 2024 | $369.98M | +23.0% |
| Q4 FY2023 | Dec 31, 2023 | $354.00M | +34.5% |
| Q3 FY2023 | Sep 30, 2023 | $319.95M | +33.7% |
| Q2 FY2023 | Jun 30, 2023 | $321.70M | +43.8% |
| Q1 FY2023 | Mar 31, 2023 | $300.78M | +44.0% |
| Q4 FY2022 | Dec 31, 2022 | $263.17M | +103.1% |
| Q3 FY2022 | Sep 30, 2022 | $239.29M | +134.4% |
| Q2 FY2022 | Jun 30, 2022 | $223.72M | +121.4% |
| Q1 FY2022 | Mar 31, 2022 | $208.88M | +125.8% |
| Q4 FY2021 | Dec 31, 2021 | $129.56M | +37.6% |
| Q3 FY2021 | Sep 30, 2021 | $102.07M | +15.3% |
| Q2 FY2021 | Jun 30, 2021 | $101.06M | +53.1% |
| Q1 FY2021 | Mar 31, 2021 | $92.51M | +2.0% |
| Q4 FY2020 | Dec 31, 2020 | $94.15M | +5.4% |
| Q3 FY2020 | Sep 30, 2020 | $88.54M | +3.2% |
| Q2 FY2020 | Jun 30, 2020 | $66.01M | -23.0% |
| Q1 FY2020 | Mar 31, 2020 | $90.70M | +4.8% |
| Q4 FY2019 | Dec 31, 2019 | $89.35M | +3.6% |
| Q3 FY2019 | Sep 30, 2019 | $85.78M | -3.5% |
| Q2 FY2019 | Jun 30, 2019 | $85.71M | +0.2% |
| Q1 FY2019 | Mar 31, 2019 | $86.51M | +4.7% |
| Q4 FY2018 | Dec 31, 2018 | $86.27M | +6.2% |
| Q3 FY2018 | Sep 30, 2018 | $88.90M | +11.2% |
| Q2 FY2018 | Jun 30, 2018 | $85.57M | -3.7% |
| Q1 FY2018 | Mar 31, 2018 | $82.63M | +1.6% |
| Q4 FY2017 | Dec 31, 2017 | $81.24M | +9.3% |
| Q3 FY2017 | Sep 30, 2017 | $79.94M | +9.4% |
| Q2 FY2017 | Jun 30, 2017 | $88.84M | – |
| Q1 FY2017 | Mar 31, 2017 | $81.36M | – |
| Q4 FY2016 | Dec 31, 2016 | $74.35M | – |
| Q3 FY2016 | Sep 30, 2016 | $73.06M | – |
See a number that looks wrong?